Tocilizumab weekly vs placebo + 52‐week taper
Proportion of participants who did not need escape therapy (as defined by study investigators) · adults aged over 50 years with giant cell arteritis
Tocilizumab weekly probably leads to higher proportion of participants who did not need escape therapy (as… compared with placebo + 52‐week taper (moderate certainty).
1 finding from 1 review
- RR 1.71 [1.24, 2.35]1 study · 151 participantsModerate